EBI-006

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEBI-006

Drug Alias NameEBI-006EBI-018EBI-028EBI-029

ClassificationBiologics

Mechanisms of ActionInterleukin-17 receptor A antagonistsIL-6 receptor antagonistsInterleukin-1 receptor antagonists

TargetsIL-6 receptorInterleukin-1 receptorInterleukin-17 receptor A

Therapy Area/IndicationsOcular inflammationUveitisMacular Degeneration

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSesen Bio Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSesen Bio Inc

Active IndicationsN/A

Inactive IndicationsOcular inflammationUveitisMacular Degeneration

ATC CodeN/A